NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Charming Medical Ltd. (“Charming” or the “Company”) (NASDAQ: MCTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
The class action concerns whether Charming and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until February 17, 2026 to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Charming securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.
[Click here for information about joining the class action]
On November 11, 2025, Charming’s stock reached a closing price of $29.36, with an intraday high of $31.70. At that time, the Company had approximately 17.18 million shares outstanding, giving it a market capitalization of around $504 million. Then, during aftermarket trading hours on November 11, 2025, the U.S. Securities and Exchange Commission (“SEC”) issued an order halting trading of Charming securities from November 12 through 25, 2025. The SEC’s order detailed how scammers had used social media to artificially inflate the price of Charming stock by influencing investors to buy and hold Charming shares. Public reports have since alleged that Charming’s stock was used as a primary vehicle for an illicit “pump-and-dump” stock promotion scheme.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980
